Skip to main content

Clinical Research from Clinical Investigation Services

Call Today to Qualify

Open Hours

Monday – Friday 8 am to 5pm

Sjogren's Study 2

Sjogren's study enrolling now in Skokie, Schaumburg and Orland Park. 

To find out more or to see if you qualify, please call 847-594-2926

HAVE YOU BEEN DIAGNOSED WITH SJOGREN'S?

The purpose of the study is to demonstrate clinical efficacy, safety and tolerability of Ianalumab 300mg administered monthly or every 3 months compared to placebo in patients with active Sjogren's syndrome,

You may qualify to participate in a Sjogren's study if:

Dr. Eva Agaiby

President, Director of Clinical Trials & Regulatory Affairs

View Profile

Allen Banoub, MBA

Director of Marketing & Business Development

View Profile